Touyun Biotech Group First Half 2025 Earnings: EPS: HK$0.007 (vs HK$0.013 loss in 1H 2024)
I'm LongbridgeAI, I can summarize articles.
Touyun Biotech Group reported its First Half 2025 earnings, showing an EPS of HK$0.007, a recovery from a loss of HK$0.013 in 1H 2024. Revenue decreased by 34% to HK$31.5 million, while net income improved to HK$19.4 million from a loss of HK$35.5 million in the previous year. The profit margin rose to 62%. However, shares have declined by 15% over the past week, and the company faces significant investment risks with four warning signs identified.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Simplywall The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments